Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 7 studies | 24% ± 7% | |
classical monocyte | 7 studies | 22% ± 7% | |
endothelial cell | 5 studies | 19% ± 2% | |
retinal ganglion cell | 4 studies | 54% ± 27% | |
monocyte | 3 studies | 22% ± 6% | |
pancreatic A cell | 3 studies | 30% ± 10% | |
conventional dendritic cell | 3 studies | 32% ± 8% | |
neuron | 3 studies | 19% ± 2% | |
myeloid cell | 3 studies | 26% ± 2% | |
epithelial cell | 3 studies | 32% ± 0% | |
GABAergic neuron | 3 studies | 25% ± 4% | |
glutamatergic neuron | 3 studies | 38% ± 6% | |
dendritic cell | 3 studies | 39% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9897.95 | 1445 / 1445 | 100% | 57.03 | 183 / 183 |
liver | 100% | 7072.79 | 226 / 226 | 100% | 84.94 | 406 / 406 |
stomach | 100% | 7055.07 | 359 / 359 | 100% | 60.67 | 286 / 286 |
lung | 100% | 8472.77 | 577 / 578 | 100% | 59.98 | 1155 / 1155 |
intestine | 100% | 10056.38 | 966 / 966 | 100% | 52.27 | 526 / 527 |
kidney | 100% | 8565.04 | 89 / 89 | 100% | 104.01 | 899 / 901 |
breast | 100% | 5586.21 | 459 / 459 | 100% | 58.75 | 1113 / 1118 |
prostate | 100% | 8571.20 | 244 / 245 | 100% | 66.45 | 501 / 502 |
skin | 99% | 3728.77 | 1798 / 1809 | 100% | 108.19 | 472 / 472 |
adrenal gland | 100% | 5922.38 | 258 / 258 | 99% | 73.25 | 227 / 230 |
uterus | 100% | 7387.44 | 170 / 170 | 99% | 44.92 | 453 / 459 |
bladder | 100% | 9162.90 | 21 / 21 | 99% | 46.80 | 497 / 504 |
thymus | 100% | 5319.58 | 651 / 653 | 98% | 54.74 | 592 / 605 |
brain | 97% | 5907.72 | 2567 / 2642 | 100% | 53.61 | 704 / 705 |
pancreas | 96% | 3815.85 | 316 / 328 | 100% | 64.81 | 178 / 178 |
ovary | 87% | 2658.48 | 157 / 180 | 96% | 30.02 | 414 / 430 |
adipose | 100% | 6427.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 12692.57 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 154.17 | 80 / 80 |
muscle | 100% | 20437.89 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5793.79 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.74 | 1 / 1 |
heart | 98% | 14423.48 | 842 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 27.06 | 26 / 29 |
peripheral blood | 62% | 1602.82 | 572 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042059 | Biological process | negative regulation of epidermal growth factor receptor signaling pathway |
GO_0050860 | Biological process | negative regulation of T cell receptor signaling pathway |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0050868 | Biological process | negative regulation of T cell activation |
GO_0035335 | Biological process | peptidyl-tyrosine dephosphorylation |
GO_0050922 | Biological process | negative regulation of chemotaxis |
GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
GO_0046329 | Biological process | negative regulation of JNK cascade |
GO_0016311 | Biological process | dephosphorylation |
GO_0051893 | Biological process | regulation of focal adhesion assembly |
GO_0043409 | Biological process | negative regulation of MAPK cascade |
GO_0120183 | Biological process | positive regulation of focal adhesion disassembly |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_1990264 | Biological process | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity |
GO_0001772 | Cellular component | immunological synapse |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0008138 | Molecular function | protein tyrosine/serine/threonine phosphatase activity |
GO_0033549 | Molecular function | MAP kinase phosphatase activity |
GO_1990782 | Molecular function | protein tyrosine kinase binding |
GO_0016791 | Molecular function | phosphatase activity |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | DUSP3 |
Protein name | Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR) Dual specificity phosphatase 3 protein-serine/threonine phosphatase (EC 3.1.3.16) Dual specificity protein phosphatase (EC 3.1.3.16) (EC 3.1.3.48) |
Synonyms | VHR |
Description | FUNCTION: Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines. Specifically dephosphorylates and inactivates ERK1 and ERK2. . FUNCTION: Dual specificity phosphatase able to dephosphorylate phosphotyrosine, phosphoserine and phosphothreonine residues, with a preference for phosphotyrosine as a substrate. . FUNCTION: Dual specificity phosphatase able to dephosphorylate phosphotyrosine, phosphoserine and phosphothreonine residues, with a preference for phosphotyrosine as a substrate. . |
Accessions | ENST00000590342.1 P51452 ENST00000226004.8 [P51452-1] ENST00000590935.1 ENST00000590753.1 K7ELG5 K7EPK5 K7ES89 B5BUI8 |